Have your own idea? Try our Stock Screener
Indian (NIFTY) Drug Retail Industry Analysis
UpdatedJan 10, 2025
DataAggregated Company Financials
Companies1
- 7D1.1%
- 3M26.3%
- 1Y13.4%
- YTDn/a
Over the last 7 days, the Drug Retail industry has remained flat. The past year has been better, since the industry has gained 11% in that time. Looking forward, earnings are forecast to grow by 39% annually.
Industry Valuation and Performance
Has the Indian Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 10 Jan 2025 | ₹100.7b | ₹60.0b | ₹1.0b | 100.4x | 100.4x | 1.7x |
| Sun, 08 Dec 2024 | ₹101.7b | ₹60.0b | ₹1.0b | 101.5x | 101.5x | 1.7x |
| Tue, 05 Nov 2024 | ₹80.1b | ₹58.3b | ₹760.5m | 105.4x | 105.4x | 1.4x |
| Thu, 03 Oct 2024 | ₹79.5b | ₹58.3b | ₹760.5m | 104.5x | 104.5x | 1.4x |
| Sat, 31 Aug 2024 | ₹81.2b | ₹58.3b | ₹760.5m | 106.8x | 106.8x | 1.4x |
| Mon, 29 Jul 2024 | ₹79.9b | ₹56.2b | ₹654.7m | 122x | 122x | 1.4x |
| Wed, 26 Jun 2024 | ₹82.0b | ₹56.2b | ₹654.7m | 125.2x | 125.2x | 1.5x |
| Fri, 24 May 2024 | ₹85.5b | ₹53.9b | ₹586.6m | 145.8x | 145.8x | 1.6x |
| Sun, 21 Apr 2024 | ₹83.0b | ₹53.9b | ₹586.6m | 141.5x | 141.5x | 1.5x |
| Tue, 19 Mar 2024 | ₹80.7b | ₹53.9b | ₹586.6m | 137.5x | 137.5x | 1.5x |
| Thu, 15 Feb 2024 | ₹72.1b | ₹53.9b | ₹586.6m | 122.9x | 122.9x | 1.3x |
| Sat, 13 Jan 2024 | ₹88.6b | ₹51.4b | ₹583.5m | 151.8x | 151.8x | 1.7x |
| Mon, 11 Dec 2023 | ₹86.8b | ₹51.4b | ₹583.5m | 148.7x | 148.7x | 1.7x |
| Wed, 08 Nov 2023 | ₹95.9b | ₹48.5b | ₹503.5m | 190.4x | 190.4x | 2x |
| Fri, 06 Oct 2023 | ₹91.8b | ₹48.5b | ₹503.5m | 180.5x | 182.3x | 1.9x |
| Sun, 03 Sep 2023 | ₹99.4b | ₹48.5b | ₹503.5m | 197.5x | 197.5x | 2.1x |
| Tue, 01 Aug 2023 | ₹114.4b | ₹45.6b | ₹497.6m | 229.9x | 229.9x | 2.5x |
| Thu, 29 Jun 2023 | ₹91.4b | ₹45.6b | ₹497.6m | 184.9x | 183.7x | 2x |
| Sat, 27 May 2023 | ₹97.0b | ₹46.0b | ₹497.6m | 194.9x | 194.9x | 2.1x |
| Mon, 24 Apr 2023 | ₹88.8b | ₹42.7b | ₹349.1m | 254.5x | 254.5x | 2.1x |
| Wed, 22 Mar 2023 | ₹90.7b | ₹42.7b | ₹349.1m | 260x | 260x | 2.1x |
| Fri, 17 Feb 2023 | ₹76.3b | ₹42.7b | ₹349.1m | 218.5x | 218.5x | 1.8x |
| Sun, 15 Jan 2023 | ₹74.8b | ₹40.1b | ₹386.7m | 193.6x | 193.6x | 1.9x |
| Tue, 13 Dec 2022 | ₹87.8b | ₹40.1b | ₹386.7m | 227x | 227x | 2.2x |
| Thu, 10 Nov 2022 | ₹69.0b | ₹38.2b | ₹524.1m | 131.7x | 131.7x | 1.8x |
| Sat, 08 Oct 2022 | ₹73.6b | ₹38.2b | ₹524.1m | 140.5x | 140.5x | 1.9x |
| Mon, 05 Sep 2022 | ₹88.0b | ₹38.2b | ₹524.1m | 167.9x | 167.9x | 2.3x |
| Wed, 03 Aug 2022 | ₹89.2b | ₹37.8b | ₹958.0m | 93.1x | 93.1x | 2.4x |
| Fri, 01 Jul 2022 | ₹91.5b | ₹37.8b | ₹958.0m | 95.6x | 95.6x | 2.4x |
| Sun, 29 May 2022 | ₹105.1b | ₹36.2b | ₹1.0b | 102.6x | 102.6x | 2.9x |
| Tue, 26 Apr 2022 | ₹118.5b | ₹36.2b | ₹1.0b | 115.7x | 115.7x | 3.3x |
| Thu, 24 Mar 2022 | ₹115.5b | ₹36.2b | ₹1.0b | 112.8x | 112.8x | 3.2x |
| Sat, 19 Feb 2022 | ₹122.4b | ₹36.2b | ₹1.0b | 119.5x | 119.5x | 3.4x |
| Mon, 17 Jan 2022 | ₹135.1b | ₹34.9b | ₹1.1b | 124.9x | 124.9x | 3.9x |
Price to Earnings Ratio
124.9x
Current Industry PE
- There is only one company in the Indian Drug Retail industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have declined 2.5% per year over the last three years.
- Meanwhile revenues for these companies have grown 20% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does Indian Drug Retail compare with similar industries?
| IN Market | -3.34% | |
| Consumer Staples | -1.18% | |
| Food and Staples Retail | 5.12% | |
| Drug Retail | 1.13% | |
| Food Retail | 5.60% | |
| Big Box Super Stores | 0% | |
| Food Distributors | -2.82% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MEDPLUS MedPlus Health Services | ₹842.05 | 1.1% +₹1.1b | 13.4% | PE100.4x |